BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.(NASDAQ:CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced the pricing of an underwritten public offering of (i) 13,530,780 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 3,382,695 shares of common stock and, (ii) to certain investors in lieu of common stock, pre-funded warrants to purchase 11,469,216 shares of common stock and accompanying common stock warrants to purchase an aggregate of 2,867,304 shares of common stock.
Each share of common stock and accompanying common stock warrant are being sold together at a combined public offering price of $0.79, and each pre-funded warrant and accompanying common stock warrant are being sold together at a combined public offering price of $0.789.
Each common stock warrant will have an exercise price of $0.79 per share, will be exercisable immediately and will expire five years from the date of issuance.
The story "Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering" has 1102 words across 29 sentences, which will take approximately 5 - 10 minutes for the average person to read.
Which news outlet covered this story?
The story "Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering" was covered 1 days ago by Benzinga, a news publisher based in United States.
How trustworthy is 'Benzinga' news outlet?
Benzinga is a fully independent (privately-owned) news outlet established in 2010 that covers mostly investing and business news.
The outlet is headquartered in United States and publishes an average of 0 news stories per day.
It's most recent story was published 1 days ago.
What do people currently think of this news story?
The sentiment for this story is currently Negative, indicating that people regard this as "bad news".
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
